Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Published: 17-Nov-2023

Having recently completed a successful rights issue related to the India stock market, Peter DeYoung, Piramal Pharma Ltd's CEO talks about the company's new and improved management programme, patient centricity and more

At this year's CPHI Barcelona, Manufacturing Chemist Stand Side caught up with Peter to discuss pharmaceutical market trends, such as the effects of the Inflation Reduction Act on the industry and reshoring, both in North America and India. 

He also provided updates on PPS’s Lexington sterile fill finish site, its integration with the Riverview API facility and the new plant's role in the company's ADCelerate programme (an integrated offering with the Grangemouth site providing rapid INDs for ADCs).

And, addressing complex lyophilised formulations, he also talked about API expansions at PPS sites worldwide and the global market demand for API/HPAPIs.

Manufacturing Chemist Stand Side...

'Manufacturing Chemist Stand Side' is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of 'Manufacturing Chemist Stand Side' contact Don Phares on +44 207 193 3219 or via email:

You may also like